OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiple sclerosis and the risk of systemic venous thrombosis: A systematic review
Omnya Ahmed, Ruth Geraldes, Gabriele C. DeLuca, et al.
Multiple Sclerosis and Related Disorders (2018) Vol. 27, pp. 424-430
Closed Access | Times Cited: 16

Showing 16 citing articles:

Multimorbidity disease clusters are associated with venous thromboembolism: an extended cross-sectional national study
Jonatan Ahrén, Mirnabi Pirouzifard, Björn Holmquist, et al.
Journal of Thrombosis and Thrombolysis (2024) Vol. 57, Iss. 6, pp. 898-906
Open Access | Times Cited: 7

Dysregulated haemostasis in thrombo-inflammatory disease
Paula Klavina, Gemma Leon, Annie M. Curtis, et al.
Clinical Science (2022) Vol. 136, Iss. 24, pp. 1809-1829
Open Access | Times Cited: 19

Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in mice
Tia C. L. Kohs, Meghan E. Fallon, E. Oseas, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 7, pp. 2383-2391
Open Access | Times Cited: 10

A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism
Jonatan Ahrén, Mirnabi Pirouzifard, Björn Holmquist, et al.
BMJ Open (2023) Vol. 13, Iss. 6, pp. e072934-e072934
Open Access | Times Cited: 6

Thrombin generation and activity in multiple sclerosis
Kelley R. Jordan, Iván Parra‐Izquierdo, András Gruber, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 3, pp. 407-420
Open Access | Times Cited: 10

Hemostasis Components as Therapeutic Targets in Autoimmune Demyelination
Gianmarco Abbadessa, Caterina Mainero, Simona Bonavita
Clinical Pharmacology & Therapeutics (2022) Vol. 111, Iss. 4, pp. 807-816
Closed Access | Times Cited: 5

Stroke risk in multiple sclerosis: a critical appraisal of the literature
Triantafyllos Doskas, Efthimios Dardiotis, George D. Vavougios, et al.
International Journal of Neuroscience (2022) Vol. 133, Iss. 10, pp. 1132-1152
Closed Access | Times Cited: 4

Genetic Markers for Thrombophilia and Cardiovascular Disease Associated with Multiple Sclerosis
Maria S. Hadjiagapiou, George Krashias, Elie Deeba, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2665-2665
Open Access | Times Cited: 4

Pulmonary embolism during the third cycle of alemtuzumab in a patient with relapsing multiple sclerosis
Mario Habek, Berislav Ruška, Tin Pavičić, et al.
Multiple Sclerosis and Related Disorders (2019) Vol. 35, pp. 5-6
Closed Access | Times Cited: 5

Postoperative Outcomes Following Posterior Lumbar Fusion in Patients With Multiple Sclerosis
Pramod Kamalapathy, Joshua Bell, Varun Puvanesarajah, et al.
Clinical Spine Surgery A Spine Publication (2021) Vol. 35, Iss. 1, pp. E211-E215
Closed Access | Times Cited: 5

Venous thromboembolism in multiple sclerosis: a report of two cases with pulmonary embolism on dimethyl fumarate and available data from adverse event reporting systems. Time to include disease modifying drugs in the equation?
Αθανάσιος Παπαθανασίου, Rasha Abdel‐Fahim, Christopher Gilmore, et al.
Clinical Neurology and Neurosurgery (2020) Vol. 192, pp. 105726-105726
Closed Access | Times Cited: 4

Cystic echinococcosis causing thrombosis of the inferior vena cava in a patient with multiple sclerosis treated with alemtuzumab
Ema Kantorová, Veronika Vajdová, Petra Hnilicová, et al.
Therapeutic Advances in Neurological Disorders (2020) Vol. 13
Open Access | Times Cited: 4

Role of Thrombosis in Neurodegenerative Diseases: An Intricate Mechanism of Neurovascular Complications
Samir Kumar Beura, Abhishek Panigrahi, Pooja Yadav, et al.
Molecular Neurobiology (2024) Vol. 62, Iss. 4, pp. 4802-4836
Closed Access

Cerebral venous thrombosis and pulmonary embolism following natalizumab infusion: Case series
John Soltys, Akhil Padarti, Brett Martin, et al.
Neuroimmunology Reports (2022) Vol. 2, pp. 100145-100145
Open Access | Times Cited: 2

Multiple sclerosis and glatiramer acetate: Risk factors for central retinal vein occlusion?
M.A. Pascual-Santiago, Bárbara Burgos-Blasco, Jacobo Emilio Enríquez-Fuentes, et al.
Journal Français d Ophtalmologie (2023) Vol. 46, Iss. 3, pp. 235-238
Closed Access

Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants
Charles E. Leonard, Colleen Brensinger, Warren B. Bilker, et al.
Medicina (2022) Vol. 58, Iss. 9, pp. 1171-1171
Open Access

Page 1

Scroll to top